FDA Inspection 1323506 — Shore Institute For Reproductive Medicine, P.C.
The FDA completed an inspection of Shore Institute For Reproductive Medicine, P.C. on Jun 22, 2026 in Lakewood, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 22, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Lakewood, NJ (United States)